Viewing Study NCT06553456


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2025-12-25 @ 9:24 PM
Study NCT ID: NCT06553456
Status: COMPLETED
Last Update Posted: 2025-09-30
First Post: 2024-08-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
Sponsor: Protgen Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module